Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Nov;33(11):2927–2930. doi: 10.1128/jcm.33.11.2927-2930.1995

Enzyme-linked immunosorbent assay-based inhibition test for neutralizing antibodies to polioviruses as an alternative to the neutralization test in tissue culture.

G Edevåg 1, B Wahren 1, A D Osterhaus 1, V A Sundqvist 1, M Granström 1
PMCID: PMC228608  PMID: 8576347

Abstract

A poliovirus-binding inhibition test (PoBI test) was established for the quantitative determination of antibodies to polioviruses and was evaluated in comparison with the conventional neutralization test (NT). The first step of the PoBI test is an incubation of serial dilutions of test samples with inactivated poliovirus followed by the detection of free viral epitopes by a double antibody sandwich enzyme-linked immunosorbent assay with type-specific capture polyclonal antisera and type-specific neutralizing monoclonal indicator antibodies. A comparison of the PoBI test with the conventional NT for antibodies to all three types in 100 human serum samples showed excellent correlations (r > 0.95) over a wide range of antibody concentrations. The PoBI test, not necessitating live virus and tissue culture facilities, could be a simple alternative to the NT, and the principle of the assay is potentially applicable to other microbial systems.

Full Text

The Full Text of this article is available as a PDF (314.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albrecht P., van Steenis G., van Wezel A. L., Salk J. Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S540–S544. doi: 10.1093/clinids/6.supplement_2.s540. [DOI] [PubMed] [Google Scholar]
  2. Böttiger M. Long-term immunity following vaccination with killed poliovirus vaccine in Sweden, a country with no circulating poliovirus. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S548–S551. doi: 10.1093/clinids/6.supplement_2.s548. [DOI] [PubMed] [Google Scholar]
  3. Hendriksen C. F., vd Gun J. W., Nagel J., Kreeftenberg J. G. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. J Biol Stand. 1988 Oct;16(4):287–297. doi: 10.1016/0092-1157(88)90017-0. [DOI] [PubMed] [Google Scholar]
  4. Hong H. A., Rooijakkers E. J., Ke N. T., Groen J., Osterhaus A. D. Methods for the purification of equine rabies immunoglobulin: effects on yield and biological activity. Biologicals. 1994 Mar;22(1):1–6. doi: 10.1006/biol.1994.1001. [DOI] [PubMed] [Google Scholar]
  5. Linde G. A., Granström M., Orvell C. Immunoglobulin class and immunoglobulin G subclass enzyme-linked immunosorbent assays compared with microneutralization assay for serodiagnosis of mumps infection and determination of immunity. J Clin Microbiol. 1987 Sep;25(9):1653–1658. doi: 10.1128/jcm.25.9.1653-1658.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Minor P. D., Ferguson M., Evans D. M., Almond J. W., Icenogle J. P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol. 1986 Jul;67(Pt 7):1283–1291. doi: 10.1099/0022-1317-67-7-1283. [DOI] [PubMed] [Google Scholar]
  7. Miyamura K., Nishio S., Ito A., Murata R., Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration. J Biol Stand. 1974 Jul;2(3):189–201. doi: 10.1016/0092-1157(74)90015-8. [DOI] [PubMed] [Google Scholar]
  8. Miyamura K., Tajiri E., Ito A., Murata R., Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies. J Biol Stand. 1974 Jul;2(3):203–209. doi: 10.1016/0092-1157(74)90016-x. [DOI] [PubMed] [Google Scholar]
  9. Orenstein W. A., Markowitz L., Preblud S. R., Hinman A. R., Tomasi A., Bart K. J. Appropriate age for measles vaccination in the United States. Dev Biol Stand. 1986;65:13–21. [PubMed] [Google Scholar]
  10. Osterhaus A. D., van Wezel A. L., Hazendonk T. G., UytdeHaag F. G., van Asten J. A., van Steenis B. Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of poliovirus type 1 using monoclonal antibodies versus cross-absorbed antisera. Intervirology. 1983;20(2-3):129–136. doi: 10.1159/000149381. [DOI] [PubMed] [Google Scholar]
  11. Osterhaus A. D., van Wezel A. L., van Steenis B., Drost G. A., Hazendonk T. G. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains. Intervirology. 1981;16(4):218–224. doi: 10.1159/000149270. [DOI] [PubMed] [Google Scholar]
  12. Simonsen O., Bentzon M. W., Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand. 1986 Jul;14(3):231–239. doi: 10.1016/0092-1157(86)90008-9. [DOI] [PubMed] [Google Scholar]
  13. Wood D. J., Heath A. B. Comparability of poliovirus neutralizing antibody tests. Biologicals. 1992 Dec;20(4):293–300. doi: 10.1016/s1045-1056(05)80050-8. [DOI] [PubMed] [Google Scholar]
  14. Wood D. J., Heath A. B. The Second International Standard for anti-poliovirus sera types 1, 2 and 3. Biologicals. 1992 Sep;20(3):203–211. doi: 10.1016/s1045-1056(05)80039-9. [DOI] [PubMed] [Google Scholar]
  15. van der Marel P., Hazendonk A. G., van Wezel A. L. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods. Dev Biol Stand. 1981;47:101–108. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES